Journal
Scientific Reports
Publication Date
2017
Volume
7
Document Type
Open Access Publication
DOI
10.1038/s41598-017-07814-4
Rights and Permissions
Albert BJ, Niu A, Ramani R, Marshall GR, Wender PA, Williams RM, Ratner L, Barnes AB, Kyei GB. Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation. Sci Rep. 2017 Aug 7;7(1):7456. doi: 10.1038/s41598-017-07814-4. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Copyright The Author(s) 2017
Recommended Citation
Albert, Brice J.; Niu, Austin; Ramani, Rashmi; Marshall, Garland R.; Wender, Paul A.; Williams, Robert M.; Ratner, Lee; Barnes, Alexander B.; and Kyei, George B., "Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation." Scientific Reports. 7, (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6088
